Stifel lowered the firm’s price target on Iqvia (IQV) to $220 from $273 and keeps a Buy rating on the shares. The firm, which believes the nearly 11% decline in the stock price was a function of AI concerns and the lower-than-expected 2026 EPS guidance, believes the AI concerns are “misguided,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target lowered to $200 from $230 at Citi
- Iqvia price target lowered to $210 from $230 at Barclays
- Iqvia sees FY26 revenue $17.15B-$17.35B, consensus $17.08B
- Iqvia reports Q4 adjusted EPS $3.42, consensus $3.40
- IQVIA: Improving Fundamentals, Easing Industry Headwinds, and 2026 Growth Visibility Support Buy Rating